Lanean...
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches to vaccine design were applied for this purpose,...
Gorde:
| Argitaratua izan da: | Vavilovskii Zhurnal Genet Selektsii |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094037/ https://ncbi.nlm.nih.gov/pubmed/33959697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18699/VJ20.676 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|